Correlation Between Neurosense Therapeutics and Pasithea Therapeutics

Can any of the company-specific risk be diversified away by investing in both Neurosense Therapeutics and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurosense Therapeutics and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurosense Therapeutics and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Neurosense Therapeutics and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurosense Therapeutics with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurosense Therapeutics and Pasithea Therapeutics.

Diversification Opportunities for Neurosense Therapeutics and Pasithea Therapeutics

0.07

Correlation Coefficient

Neurosense Therapeutics  Pasithea Therapeutics

Significant diversification

The 3 months correlation between Neurosense and Pasithea is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Neurosense Therapeutics and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Neurosense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurosense Therapeutics are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Neurosense Therapeutics i.e., Neurosense Therapeutics and Pasithea Therapeutics go up and down completely randomly.

Pair Corralation between Neurosense Therapeutics and Pasithea Therapeutics

Given the investment horizon of 90 days Neurosense Therapeutics is expected to under-perform the Pasithea Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Neurosense Therapeutics is 5.1 times less risky than Pasithea Therapeutics. The stock trades about -0.24 of its potential returns per unit of risk. The Pasithea Therapeutics Corp is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  1.80  in Pasithea Therapeutics Corp on September 17, 2024 and sell it today you would earn a total of  0.50  from holding Pasithea Therapeutics Corp or generate 27.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	50.0%
Values	Daily Returns

Neurosense Therapeutics  vs.  Pasithea Therapeutics Corp

Neurosense Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurosense Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pasithea Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Pasithea Therapeutics Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neurosense Therapeutics and Pasithea Therapeutics

The main advantage of trading using opposite Neurosense Therapeutics and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurosense Therapeutics position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.

The idea behind Neurosense Therapeutics and Pasithea Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.